CRANSTON MARY B 4

What Happened Mary B. Cranston, a director of Chemours Co. (CC), was granted/received 7,182 shares on May 6, 2026. The reported acquisition price is $0.00 (code A — award/grant), so the transaction shows no cash paid. The Form 4 covering the transaction was filed on May 8, 2026.

Key Details

• Transaction date: 2026-05-06; filing date: 2026-05-08.
• Transaction type/code: Award/Grant (A).
• Shares acquired: 7,182; reported acquisition price: $0.00 (total cash paid $0).
• Shares owned after transaction: not specified in the summary provided — see the Form 4 for post-transaction total holdings.
• Footnotes: F1 — total holdings were adjusted to correct an administrative error in prior Form 4s; F2 — holdings include deferred stock units and dividend equivalent units.
• No late filing flag was indicated in the information provided.

Context This was an equity award (likely compensation or deferred/unit-based award), not an open-market purchase or sale. Awards and deferred units are common components of director compensation and do not, by themselves, indicate the director is buying or selling shares in the market. The filing also corrects prior reporting of total holdings, so consult the full Form 4 for the updated holding totals.